default author photo

Ismail Ahmad

Universiti Teknologi MARA (UiTM)

40450 Shah Alam

Johor

Dungun, Selangor 23000

Malaysia

SCHOLARLY PAPERS

2

DOWNLOADS

379

TOTAL CITATIONS

6

Scholarly Papers (2)

1.

A Partially-Randomised Phase 3 Trial of Pretomanid, Moxifloxacin and Pyrazinamide in Combination for the Treatment of Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis

Number of pages: 151 Posted: 14 Feb 2020
University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, Kenyatta National Hospital, National Centre for Pulmonary Research, Pusat Perubatan Universiti Kebangsaan, University College London, Global Alliance for TB Drug Development, Aurum Institute for Health Research, Makati Medical Centre, Johns Hopkins University - School of Medicine, St. Andrews University, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), University of Cape Town Lung Institute, Global Alliance for TB Drug Development, Stellenbosch University, Global Alliance for TB Drug Development, University College London - MRC Clinical Trials Unit, University College London, Universiti Teknologi MARA (UiTM), Wentworth Hospital, Global Alliance for TB Drug Development, Madibeng Centre for Research, Setshaba Research Centre, University College London, Global Alliance for TB Drug Development, Ifakara Health Institute, THINK TB & HIV Investigative Network, Kenya Medical Research Institute (KEMRI) - Centre for Respiratory Diseases Research, University College London - MRC Clinical Trials Unit, National Institute for Medical Research (NIMR), Aurum Institute for Health Research, Aurum Institute for Health Research, University of Nebraska Medical Center, University of Nebraska Medical Center, affiliation not provided to SSRN, Klerksdorp-Tshepong Hospital Complex - Department of Medicine, Global Alliance for TB Drug Development and St. Andrews University
Downloads 217 (353,017)
Citation 6

Abstract:

Loading...

Tuberculosis; TB; drug-sensitive tuberculosis; DS-TB; MDR-TB; multidrug-resistant TB; regimen development; pretomanid, moxifloxacin, pyrazinamide; ethambutol; HRZE, phase 3 clinical trial; PaMZ

2.

Loan Loss Provisions and Earnings Management in Malaysian Banking Industry

Global Journal of Business and Social Science Review, Vol. 1(1) 2013. 93-104
Number of pages: 12 Posted: 18 Jul 2017 Last Revised: 21 Jul 2018
Hasni Abdullah, Imbarine Bujang and Ismail Ahmad
Universiti Teknologi MARA (UiTM), Universiti Teknologi MARA (UiTM) and Universiti Teknologi MARA (UiTM)
Downloads 162 (461,984)

Abstract:

Loading...

Loan Loss Provisions; Earnings Management; Capital Management; Macroeconomic Factors; Commercial Banks